메뉴 건너뛰기




Volumn 14, Issue 12, 2000, Pages 1857-1858

Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; LAMIVUDINE; NUCLEOSIDE ANALOG; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; THYMIDINE KINASE; VIRUS RNA; ZIDOVUDINE;

EID: 0033823257     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200008180-00025     Document Type: Article
Times cited : (50)

References (8)
  • 5
    • 0032585237 scopus 로고    scopus 로고
    • Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferonα2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
    • (1998) Lancet , vol.352 , pp. 1426-1432
    • Poynard, T.1    Marcellin, P.2    Lee, S.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.